Medicare’s proposed increase for inpatient payments in FY23 doesn’t meet hospitals’ expectations
The hospital industry expressed disappointment with the proposed increase for inpatient payments in FY23.
Federal funding bill addresses 340B eligibility concerns but not some other points of interest for hospitals
An FY22 appropriations bill allows hospitals to remain in the 340B Drug Pricing Program if their eligibility had been adversely affected by the COVID-19 pandemic.
For some 340B hospitals, the COVID-19 pandemic has brought an unanticipated and unwelcome loss of eligibility
Bringing longer stays and higher rates of deferred care, the COVID-19 pandemic is adversely affecting 340B eligibility for some hospitals.
HHS can continue using Worksheet S-10 to calculate uncompensated care payments after federal court ruling
A federal district court dealt hospitals a defeat in a case about uncompensated care payments, issuing a summary judgment in favor of the U.S. Department of Health and Human Services.
Current financial reporting practices inhibit healthcare policymaking, researchers say
Creation of a national database with information from health systems’ audited financial statements would give policymakers a better sense of how to respond to financial trends, according to researchers.
OIG report suggests Medicare pays too much to cover capital costs for new hospitals
A new federal report indicates CMS pays excessively to cover capital expenditures during the first two years of a hospital’s existence.
FY22 rule for the Inpatient Prospective Payment System finalizes a payment increase and key policy updates
The base payment increase for hospital inpatient services in FY22 will be 2.5%, according to a final rule issued by CMS.
Healthcare leaders offer direction on key CMS inpatient proposals for FY 2022
HFMA offers direction to CMS on several of its key inpatient proposals for 2021 as many healthcare leaders have expressed concern about these proposals.
In a win for hospitals, CMS removes a rate-reporting requirement from the Medicare FY22 Inpatient Prospective Payment System
An FY22 requirement for hospitals to disclose privately negotiated MA rates on their Medicare cost reports has been rescinded in the proposed rule for the Inpatient Prospective Payment System.
HHS should ensure 340B hospitals remain eligible despite changes in payer mix, AHA says
Hospitals participating in the 340B Drug Pricing Program could lose access due to payer mix changes stemming from the COVID-19 pandemic unless HHS issues a waiver.